These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 28724315)

  • 41. Magnetic resonance post-contrast T1 mapping in the human atrium: validation and impact on clinical outcome after catheter ablation for atrial fibrillation.
    Ling LH; McLellan AJ; Taylor AJ; Iles LM; Ellims AH; Kumar S; Teh A; Lee G; Wong MC; Azzopardi S; Sellenger MA; Morton JB; Kalman JM; Kistler PM
    Heart Rhythm; 2014 Sep; 11(9):1551-9. PubMed ID: 24931636
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of Voltage Mapping to Guide Whether to Perform Ablation of the Posterior Wall in Patients With Persistent Atrial Fibrillation.
    Cutler MJ; Johnson J; Abozguia K; Rowan S; Lewis W; Costantini O; Natale A; Ziv O
    J Cardiovasc Electrophysiol; 2016 Jan; 27(1):13-21. PubMed ID: 26515166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Midterm outcomes of two-staged hybrid ablation of persistent and long-standing persistent atrial fibrillation using the versapolar epicardial surgical device and subsequent catheter ablation.
    Budera P; Osmancik P; Herman D; Zdarska J; Talavera D; Mala A; Prochazkova R; Straka Z
    J Interv Card Electrophysiol; 2017 Nov; 50(2):187-194. PubMed ID: 28921386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of different termination modes on atrial fibrillation termination in catheter ablation of persistent atrial fibrillation.
    Wang P; Dong JZ; Long DY; Ning M; Tang RB; Yu RH; Xue ZM; Sang CH; Jiang CX; Ma CS
    Chin Med J (Engl); 2012 Jun; 125(11):1877-83. PubMed ID: 22884046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective ablation or isolation of all pulmonary veins in atrial fibrillation -- when and for whom?
    Walczak F; Szumowski L; Urbanek P; Szufladowicz E; Derejko P; Kułakowski P; Baranowski R; Bodalski R; Kepski R; Zagrodzka M; Onish K; Bestry I; Konka M; Kuśnierczyk B; Maryniak A
    Kardiol Pol; 2006 Jan; 64(1):26-35; discussion 36-7. PubMed ID: 16444625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography.
    Wang YC; Lin LC; Lin MS; Lai LP; Hwang JJ; Tseng YZ; Tseng CD; Lin JL
    Cardiology; 2005; 104(4):202-9. PubMed ID: 16155395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.
    Haïssaguerre M; Hocini M; Sanders P; Sacher F; Rotter M; Takahashi Y; Rostock T; Hsu LF; Bordachar P; Reuter S; Roudaut R; Clémenty J; Jaïs P
    J Cardiovasc Electrophysiol; 2005 Nov; 16(11):1138-47. PubMed ID: 16302893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of atrial fibrillation.
    Hersi A; Wyse DG
    Curr Probl Cardiol; 2005 Apr; 30(4):175-233. PubMed ID: 15778690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
    Blackshear JL; Safford RE; ;
    Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ischemic stroke phenotype in patients with nonsustained atrial fibrillation.
    Arsava EM; Bas DF; Atalar E; Has AC; Oguz KK; Topcuoglu MA
    Stroke; 2015 Mar; 46(3):634-40. PubMed ID: 25634003
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rhythm outcome predictors after concomitant surgical ablation for atrial fibrillation: a 9-year, single-center experience.
    Pecha S; Schäfer T; Subbotina I; Ahmadzade T; Reichenspurner H; Wagner FM
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):428-33. PubMed ID: 24139897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biatrial linear ablation in sustained nonpermanent AF: Results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial.
    Wynn GJ; Panikker S; Morgan M; Hall M; Waktare J; Markides V; Hussain W; Salukhe T; Modi S; Jarman J; Jones DG; Snowdon R; Todd D; Wong T; Gupta D
    Heart Rhythm; 2016 Feb; 13(2):399-406. PubMed ID: 26455343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Atrial fibrillation management: evaluating rate vs rhythm control.
    Nguyen T; Jolly U; Sidhu K; Yee R; Leong-Sit P
    Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):713-24. PubMed ID: 26960034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardioversion differences among first detected episode, paroxysmal, and persistent atrial fibrillation patients in the RHYTHM AF registry in Poland.
    Kiliszek M; Opolski G; Włodarczyk P; Ponikowski P
    Cardiol J; 2015; 22(4):453-8. PubMed ID: 25588533
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: results from a randomized prospective study.
    Nührich JM; Steven D; Berner I; Rostock T; Hoffmann B; Servatius H; Sultan A; Lüker J; Treszl A; Wegscheider K; Willems S
    Heart Rhythm; 2014 Sep; 11(9):1536-42. PubMed ID: 24907643
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological differences of the spontaneous onset of paroxysmal and persistent atrial fibrillation.
    Weber S; Ndrepepa G; Schneider M; Deisenhofer I; Zrenner B; Schmitt C
    Pacing Clin Electrophysiol; 2007 Mar; 30(3):295-303. PubMed ID: 17367348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term results of radiofrequency catheter ablation of long-lasting persistent atrial fibrillation: five years of follow-up].
    Ardashev AV; Zheliakov EG; Dupliakov DV; Konev AV; Rybachenko MS; Glukhova VL; Golovina GA; Skuratova MA; Fin'ko VA; Belenkov IuN
    Kardiologiia; 2013; 53(6):4-11. PubMed ID: 23953039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ablation of atrial fibrillation in patients ≥75 years: long-term clinical outcome and safety.
    Metzner I; Wissner E; Tilz RR; Rillig A; Mathew S; Schmidt B; Chun J; Wohlmuth P; Deiss S; Lemes C; Maurer T; Fink T; Heeger C; Ouyang F; Kuck KH; Metzner A
    Europace; 2016 Apr; 18(4):543-9. PubMed ID: 26826139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duty-cycled unipolar/bipolar versus conventional radiofrequency ablation in paroxysmal and persistent atrial fibrillation.
    Tivig C; Dang L; Brunner-La Rocca HP; Özcan S; Duru F; Scharf C
    Int J Cardiol; 2012 May; 157(2):185-91. PubMed ID: 21193237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.